Weiqun Mao
- Cancer Research top 10%
- Oncology top 10%
- HER2/EGFR in Cancer Research 7
- Cancer-related Molecular Pathways 7
-
- Epigenetics and DNA Methylation 5
- Geriatrics and Gerontology top 10%
- Physiology top 10%
-
- Autophagy in Disease and Therapy 13
-
- Ovarian cancer diagnosis and treatment 5
-
- Cancer Mechanisms and Therapy 4
-
- Cell Adhesion Molecules Research 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Robert C. BastZhen LüXiao‐Feng LeAngela ThorntonHailing YangXiao-Feng LeGong YangJinyun Liu
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Weiqun Mao
32 papers receiving 886 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 217
- Oncology 310
- Molecular Biology 546
- Geriatrics and Gerontology 28
- Physiology 32
Countries citing papers authored by Weiqun Mao
This map shows the geographic impact of Weiqun Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqun Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqun Mao more than expected).
Fields of papers citing papers by Weiqun Mao
This network shows the impact of papers produced by Weiqun Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqun Mao. The network helps show where Weiqun Mao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiqun Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 13 | |
| 3 | 2019 | 19 | |
| 4 | 2018 | 32 | |
| 5 | 2016 | 48 | |
| 6 | 2016 | 24 | |
| 7 | 2015 | 51 | |
| 8 | 2015 | 29 | |
| 9 | 2015 | 11 | |
| 10 | 2014 | 30 | |
| 11 | 2012 | 58 | |
| 12 | 2011 | 23 | |
| 13 | 2010 | 71 | |
| 14 | 2009 | 23 | |
| 15 | 2008 | 45 | |
| 16 | 2007 | 37 | |
| 17 | 2006 | 20 | |
| 18 | 2006 | 134 | |
| 19 | Growth arrest induced by anti-HER2 antibody blocks breast cancer cells in the late G1 phase of the cell cycle | 2005 | 5 |
| 20 | 2004 | 58 |
About Weiqun Mao
Weiqun Mao is a scholar working on Physiology, Reproductive Medicine and Immunology and Allergy, having authored 33 papers that have together received 896 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (13 papers), HER2/EGFR in Cancer Research (7 papers), Cancer-related Molecular Pathways (7 papers), Epigenetics and DNA Methylation (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer Mechanisms and Therapy (4 papers), Cell Adhesion Molecules Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Cancer Research (217 citations), Oncology (310 citations) and Molecular Biology (546 citations). Weiqun Mao has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Robert C. Bast, Zhen Lü, Xiao‐Feng Le, Angela Thornton, Hailing Yang, Xiao-Feng Le, Gong Yang, Jinyun Liu, Margie N. Sutton and Bing Z. Carter. Their work appears in journals such as Cancer Research, Cancer, Cancers, Clinical Cancer Research and Autophagy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.